Epidemiological evidence and molecular basis of interactions between HIV and JC virus

References

• Amemiya K, Traub R, Durham L, Major EO (1992). Adjacent nuclear factor-1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain-specific genes. J Biol Chem 267: 14204–14211.
   Google Scholar
• Arroyo EJ, Bermingham JR Jr, Rosenfeld MG, Scherer SS (1998). Promyelinating Schwann cells express Tst-1/SCIP/Oct-6. J Neurosci 18: 7891–7902.
   PubMedGoogle Scholar
• Astrom K, Mancall E, Richardson EJ (1958). Progressive multifocal leukoencephalopathy. Brain 81: 93–127.
   PubMed Web of Science ®Google Scholar
• Atwood WJ, Amemiya K, Traub R, Harms J, Major EO (1992). Interaction of the human polyomavirus, JCV, with human B-lymphocytes. Virology 190: 716–723.
   PubMed Web of Science ®Google Scholar
• Atwood WJ, Wang L, Durham LC, Amemiya K, Traub RG, Major EO (1995). Evaluation of the role of cytokine acti-vation in the multiplication of JC virus (JCV) in human fetal glial cells. I Neurovirol 1: 40–49.
   Web of Science ®Google Scholar
• Bacellar H, Munoz A, Miller EN, Cohen BA, Besley D, Seines OA, Becker JT, McArthur JC (1994). Temporal trends in the incidence of HIV-1-related neurologic dis-eases: multicenter AIDS cohort study, 1985–1992. Neu-rology 44: 1892–1900.
   Google Scholar
• Baril L, Jouan M, Agher R, Cambau E, Caumes E, Bricaire F, Katlama C (2000). Impact of highly active antiretrovi-ral therapy on onset of Mycobacterium avium complex infection and cytomegalovirus disease in patients with AIDS. AIDS 14: 2593–2596.
   Google Scholar
• Berger JR, Kaszovitz B, Post MJ, Dickinson G (1987). Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A re-view of the literature with a report of sixteen cases. Ann Intern Med 107: 78–87.
   Google Scholar
• Berger JR, Levy RM, Flomenhoft D, Dobbs M (1998a). Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 44: 341–349.
   Google Scholar
• Berger JR, Major EO (1999). Progressive multifocal leukoen-cephalopathy. Semin Neurol 19: 193–200.
   PubMed Web of Science ®Google Scholar
• BergerJR, Nath A, Greenberg RN, Andersen AH, Greene RA, Bognar A, Avison MJ (2000). Cerebrovascular changes in the basal ganglia with HIV dementia. Neurology 54: 921–926.
   Google Scholar
• Berger JR, Pall L, Lanska D, Whiteman M (1998b). Progres-sive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 4: 59–68.
   Google Scholar
• Brooks BR, Walker DL (1984). Progressive multifocal leukoencephalopathy. Neurol Clin 2: 299–313.
   PubMed Web of Science ®Google Scholar
• Chang HC, Samaniego F, Nair BC, Buonaguro L, Ensoli B (1997). HIV-1 tat protein exits from cells via a leader-less secretory pathway and binds to extracellelarmatrix-associated heparan sulfate proteoglycan through its basic region. AIDS 11: 1421–1431.
   PubMed Web of Science ®Google Scholar
• Chen P, Mayne M, Power C, Nath A (1997). The Tat protein of HIV-1 induces tumor necrosis factor-a pro-duction: implications for HIV associated neurological diseases. J Biol Chem 272: 22385–22388.
   PubMed Web of Science ®Google Scholar
• Chowdhury M, Taylor JP, Chang CF, Rappaport J, Khalili K (1992). Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. I Virol 66: 7355–7361.
   PubMedGoogle Scholar
• Chowdhury M, Taylor JP, Tada H, Rappaport J, Wong-Staal F, Amini S, Khalili K (1990). Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein. Oncogene 5: 1737–1742.
   PubMedGoogle Scholar
• Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO (1998). Induction of monocyte chemotactic protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Nati Acad Sci USA 95: 3117–3121.
   PubMed Web of Science ®Google Scholar
• Cota M, Kleinschmidt A, Ceccherini-Silberstein F, Aloisi F, Mengozzi M, Mantovani A, Brack-Werner R, Poli G (2000). Upregulated expression of interleukin-8, RANTES and chemokine receptors in human astrocytic cells infected with HIV-1. I NeuroVirol 6: 75–83.
   PubMed Web of Science ®Google Scholar
• Couraud PO (1998). Infiltration of inflammatory cells through brain endothelium. Pathol Biol (Paris) 46: 176–180.
   PubMed Web of Science ®Google Scholar
• Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA, Achim CL (1999). Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 155: 1915–1927.
   Google Scholar
• d'Arminio Monforte A, Duca PG, Vago L, Grassi MP, Moroni M (2000). Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy. Neurology 54: 1856–1859.
   Google Scholar
• D'Souza M, Fauci A, (1999). Immunopathogenesis. In: Text-book of AIDS medicine. Merigan TJ, Bartlett J, Bolognesi D, (eds). Baltimore, MD: Williams and Wilkins, pp 59–86.
   Google Scholar
• Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F (1990). Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345: 84–86.
   PubMed Web of Science ®Google Scholar
• Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC (1993). Release, uptake, and effects of extracellular human immunodefi-ciency virus type-1 Tat protein on cell growth and viral replication. I Virol 67: 277–287.
   PubMed Web of Science ®Google Scholar
• Gallia GL, Darbinian N, Tretiakova A, Ansari SA, Rappaport J, et al (1999). Association of HIV-1 Tat with the cellular protein, Puralpha, is mediated by RNA. Proc Nati Acad Sci USA 96: 11572–11577.
   PubMedGoogle Scholar
• Gillespie SM, Chang Y, Lemp G, Arthur R, Buchbinder S, et al (1991). Progressive multifocal leukoencephalopa-thy in persons infected with human immunodeficiency virus, San Francisco, 1981–1989. Ann Neurol 30: 597–604.
   Google Scholar
• Gringeri A, Santagostino E, Muca-Perja M, Le Buanec H, Bizzini B, et al (1999). Tat toxoid as a component of a preventive vaccine in seronegative subjects. I Acquir Immune Defic Syndr Hum Retrovirol 20: 371–375.
   PubMedGoogle Scholar
• Gringeri A, Santagostino E, Muca-Perja M, Mannucci PM, Zagury JF, et al (1998). Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients. J Hum Virol 1: 293–298.
   PubMedGoogle Scholar
• Harmon WE (1991). Opportunistic infections in children following renal transplantation. Pediatr Nephrol 5: 118–125.
   Google Scholar
• Hofman FM, Dohadwala MM, Wright AD, Hinton DR, Walker SM (1994). Exogenous tat protein activates cen-tral nervous system-derived endothelial cells. I Neu-roimmunol 54: 19–28.
   PubMed Web of Science ®Google Scholar
• Holman RC, Janssen RS, Buehler JW, Zelasky MT, Hooper WC (1991). Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data. Neurol-ogy 41: 1733–1736.
   PubMed Web of Science ®Google Scholar
• Houff SA, Major EO, Katz DA, Kufta CV, Sever JL, Pittaluga S, Roberts JR, Gitt J, Saini N, Lux W (1988). Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. NEng/JMed 318: 301–305.
   Google Scholar
• Ilyin SE, Plata-Salaman CR (1997). HIV-1 gp 120 modulates hypothalamic cytokine mRNAs in vivo: implications to cytokine feedback systems. Biochem Biophys Res Com-mun 231: 514–518.
   Google Scholar
• Johnston JB, Zhang K, Silva C, Shalinsky DR, Conant K, eta] (2001). HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann Neurol 49: 230–241.
   PubMed Web of Science ®Google Scholar
• Kruman II, Nath A, Maragos WF, Chan SL, Jones M, et al (1999). Evidence that Par-4 participates in the pathogen-esis of AIDS dementia. Am J Pathol 155: 39–46.
   Google Scholar
• Krupp LB, Lipton RB, Swerdlow ML, Leeds NE, Llena J (1985). Progressive multifocal leukoencephalopathy: clinical and radiographic features. Ann Neuro117: 344–349.
   Google Scholar
• Kuchelmeister K, Gullotta F, Bergmann M, Angeli G, Masini T (1993). Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS). A neuropathological autopsy study of 21 cases. Pathol Res Pract 189: 163–173.
   Google Scholar
• Kure K, Llena JF, Lyman WD, Soeiro R, Weidenheim KM, et al (1991). Human immunodeficiency virus-1 infec-tion of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol 22: 700–710.
   PubMed Web of Science ®Google Scholar
• Lang W, Miklossy J, Deruaz JP, Pizzolato GP, Probst A, et al (1989). Neuropathology of the acquired immune defi-ciency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol 77: 379–390.
   Web of Science ®Google Scholar
• Liu Y, Jones M, Hingtgen CM, Bu G, Laribee N, et al (2000). Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neu-ronal metabolic balance of the receptor ligands. Nat Med 6: 1380–1387.
   PubMed Web of Science ®Google Scholar
• Lole KS, Bollinger RC, Paranj ape RS, Gadkari D, Kulkarni SS, et al (1999). Full-length human immunodeficiency virus type 1 genomes from subtype C-infected serocon-verters in India, with evidence of intersubtype recombi-nation. I Virol 73: 152–160.
   PubMed Web of Science ®Google Scholar
• Ma M, Nath A (1997). Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. I Virol 71: 2495–2499.
   PubMed Web of Science ®Google Scholar
• Mace K, Gazzolo L (1993). Expression of the Tat protein of HIV 1 in human promonocytic U937 cells. Res Virol 144: 27–34.
   Google Scholar
• Major EO, Amemiya K, Elder G, Houff SA (1990). Glial cells of the human developing brain and B cells of the im-mune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV. I Neurosci Res 27: 461–471.
   PubMed Web of Science ®Google Scholar
• Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR (1992). Pathogenesis and molecular biology of pro-gressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 5: 49–73.
   PubMed Web of Science ®Google Scholar
• Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A (2000). Incidence and prevalence of neurological dis-orders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). I Neurol Neurosurg Psychiatry 69: 376–380.
   PubMed Web of Science ®Google Scholar
• Messite J, Stillman S (1996). Accuracy of death certificate completion. JAMA 275: 794–796.
   PubMed Web of Science ®Google Scholar
• Monaco MC, Jensen PN, Hou J, Durham LC, Major EO (1998). Detection of JC virus DNA in human tonsil tis-sue: evidence for site of initial viral infection. I Virol 72: 9918–9923.
   PubMed Web of Science ®Google Scholar
• Moses AV, Nelson JA (1994). HIV infection of human brain capillary endothelial cells: implications for AIDS de-mentia. Adv Neuroimmunol 4: 239–247.
   PubMedGoogle Scholar
• Nath A, Conant K, Chen P, Scott C, Major EO (1999). Tran-sient Exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes: a hit and run phenomenon. J Biol Chem 274: 17098–17102.
   PubMed Web of Science ®Google Scholar
• Nath A, Geiger J, Mattson M, Magnuson D, Jones M, Berger J (1998). Role of viral proteins in neuropatho-genesis of HIV infection with emphasis on Tat. (www. sciencemag.org/NAIDS) NeuroAIDS 1.
   Google Scholar
• Nottet, HS, Gendelman HE (1995). Unraveling the neu-roimmune mechanisms for the HIV-1-associated cogni-tive/motor complex. Immunol Today 16: 441–448.
   PubMedGoogle Scholar
• Nottet HS, Persidsky Y, Sasseville VG, Nukuna AN, Bock P, eta] (1996). Mechanisms for the transendothelial migra-tion of HIV-1-infected monocytes into brain. J Immunol 156: 1284–1295.
   PubMed Web of Science ®Google Scholar
• Novitsky VA, Montano MA, McLane MF, Renjifo B, Vannberg F, eta] (1999). Molecular cloning and phyloge-netic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana. I Virol 73: 4427–4432.
   Google Scholar
• Persidsky Y, Buttini M, Limoges J, Bock P, Gendelman HE (1997). An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis. I NeuroVirol 3: 401–416.
   PubMed Web of Science ®Google Scholar
• Persidsky Y, Zheng J, Miller D, Gendelman HE (2000). Mononuclear phagocytes mediate blood-brain bar-rier compromise and neuronal injury during HIV-1-associated dementia. J Leuk Biol 68: 413–422.
   PubMed Web of Science ®Google Scholar
• Petito CK, Cash KS (1992). Blood-brain barrier abnor-malities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 32: 658–666.
   PubMed Web of Science ®Google Scholar
• Philippon V, Vellutini C, Gambarelli D, Harkiss G, Arbuth-nott G, et al (1994). The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines. Virology 205: 519–529.
   PubMed Web of Science ®Google Scholar
• Power C, Kong PA, Crawford TO, Wesselingh S, Glass JD, McArthur JC, Trapp BD (1993). Cerebral white mat-ter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 33: 339–350.
   Google Scholar
• Quagliarello VJ, Wispelwey B, Long WJ, Scheld WM (1991). Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characteriza-tion and comparison with tumor necrosis factor. I Clin Invest 87: 1360–1366.
   Google Scholar
• Raj GV, Khalili K (1994). Identification and characterization of a novel GGA/C-binding protein, GBP-i, that is rapidly inducible by cytokines. Mol Cell Biol 14: 7770–7781.
   PubMedGoogle Scholar
• Renner K, Leger H, Wegner M (1994). The POU domain pro-tein Tst-1 and papovaviral large tumor antigen function synergistically to stimulate glia-specific gene expression of JC virus. Proc Nat] Acad Sci USA 91: 6433–6437.
   Google Scholar
• Robert-Guroff M, Popovic M, Gartner S, Markham P, Gallo RC, Reitz MS (1990). Structure and expression of tat-, rev-, and nef-specific transcripts of human immuno-deficiency virus type 1 in infected lymphocytes and macrophages. I Virol 64: 3391–3398.
   PubMedGoogle Scholar
• Satishchandra P, Nalini A, Gourie-Devi M, Khanna N, Santosh V, et al (2000). Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989–96). Indian J Med Res 111: 14–23.
   Google Scholar
• Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF (1999). In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285: 1569–1572.
   PubMed Web of Science ®Google Scholar
• Sock E, Enderich J, Wegner M (1999). The J domain of papovaviral large tumor antigen is required for syner-gistic interaction with the POU domain protein Tst-1/ Oct6/SCIP. Mol Cell Biol 19: 2455–2464.
   Google Scholar
• Sparano JA, Anand K, Desai J, MitnickRJ, Kalkut GE, Hanau LH (1999). Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center. J Acquir Immune Defic Syndr 21 (Suppl 1): S18–S22.
   Google Scholar
• Stoner GL, Ryschkewitsch CF, Walker DL, Webster HD (1986). JC papovavirus large tumor (T)-antigen expres-sion in brain tissue of acquired immune deficiency syn-drome (AIDS) and non-AIDS patients with progressive multifocal leukoencephalopathy. Proc Nat] Acad Sci USA 83: 2271–2275.
   Google Scholar
• Tada H, Rappaport J, Lashgari M, Amini S, Wong-Staal F, Khalili K (1990). Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunode-ficiency virus in glial cells. Proc Nat] Acad Sci USA 87: 3479–3483.
   PubMed Web of Science ®Google Scholar
• Tardieu M, Hery C, Peudenier S, Boespflug O, Montagnier L (1992). Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Ann Neurol 32: 11–17.
   Google Scholar
• Toneatto S, Finco O, van der Putten H, Abrignani S, Annunziata P (1999). Evidence of blood-brain barrier al-teration and activation in HIV-1 gp 120 transgenic mice. AIDS 13: 2343–2348.
   PubMed Web of Science ®Google Scholar
• Tornatore C, Berger JR, Houff SA, Curfman B, Meyers K, et al (1992). Detection of JC virus DNA in peripheral lymphocytes from patients with and without progres-sive multifocal leukoencephalopathy. Ann Neurol 31: 454–462.
   PubMed Web of Science ®Google Scholar
• Tretiakova A, Otte J, Croul SE, Kim JH, Johnson EM, et al (1999a). Association of JC virus large T antigen with myelin basic protein transcription factor (MEF-1/ Puralpha) in hypomyelinated brains of mice transgeni-cally expressing T antigen. I Virol 73: 6076–6084.
   PubMedGoogle Scholar
• Tretiakova A, Steplewski A, Johnson EM, Khalili K, Amini S (1999b). Regulation of myelin basic protein gene tran-scription by Sp1 and Puralpha: evidence for association of Spl and Puralpha in brain. I Cell Physiol 181: 160–168.
   PubMedGoogle Scholar
• Turchan J, Anderson AF, HK, Sun Q, Zhang J, Liu Y, Wise PM, Kruman I, Maragos W, Mattson MP, Booze R, Nath A (2001). Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neuroscience 2:
   Google Scholar
• Valle LD, Croul S, Morgello S, Amini S, Rappaport J, Khalili K (2000). Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoen-cephalopathy. I NeuroVirol 6: 221–228.
   Google Scholar
• Walker D, Padgett B (1983). The epidemiology of human polyomaviruses. In: Polyomaviruses and human neuro-logical disease. Sever J, Madden D (eds). New York: Alan R Liss, pp 99–106.
   Google Scholar
• Weiss JM, Nath A, Major EO, Berman JW (1999). HIV-Tat induces MCP-1 mediated monocyte transmigration and upregulates CCR5 expression on human monocytes. J Immunol 163: 2953–2959.
   PubMed Web of Science ®Google Scholar
• Wesselingh SL, Power C, Glass JD, Tyor WR, McArthur JC, et al (1993). Intracerebral cytokine messenger RNA ex-pression in acquired immunodeficiency syndrome de-mentia. Ann Neurol 33: 576–582.
   PubMedGoogle Scholar
• Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, et al (1995). Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp 120. Nature 375: 497–500.
   PubMed Web of Science ®Google Scholar
• Whiteman ML, Post MJ, Berger JR, Tate LG, Bell MD, Limonte LP (1993). Progressive multifocal leukoen-cephalopathy in 47 HIV-seropositive patients: neu-roimaging with clinical and pathologic correlation. Radiology 187: 233–240.
   PubMed Web of Science ®Google Scholar
• Wiley CA, Baldwin M, Achim CL (1996). Expression of reg-ulatory and structural mRNA in the central nervous sys-tem. AIDS 10: 943–947.
   Google Scholar
• Williams KC, Hickey WF (1995). Traffic of hematogenous cells through the central nervous system. Curr Top Mi-crobiol Immunol 202: 221–245.
   PubMed Web of Science ®Google Scholar
• Woodman SE, Benveniste EN, Nath A, Berman JW (1999). Human immunodeficiency virus type 1 TAT protein induces adhesion molecule expression in astrocytes. J NeuroVirol 5: 678–684.
   PubMed Web of Science ®Google Scholar
• Wortman MJ, Krachmarov CP, Kim JH, Gordon RG, Chepenik LG, et al (2000). Interaction of HIV-1 Tat with Puralpha in nuclei of human glial cells: characteriza-tion of RNA-mediated protein-protein binding. I Cell Biochem 77: 65–74.
   PubMed Web of Science ®Google Scholar
• Yoshimur a N, Oka T (1990). Medical and surgi-cal complications of renal transplantation: diagno-sis and management. Med Clin North Am 74: 1025–1037.
   Google Scholar
• Zembala M, Pryjma J, Plucienniczak A, Szczepanek A, Jasinski M, et al (1995). Interaction of HIV-1 gp 120 molecule fragments with human monocytes: different requirements for tumor necrosis factor-alpha and IL-6 production. Clin Immunol Immunopathol 75: 131–139.
   Google Scholar